脓毒性休克中血管紧张素II信号受损
本文综述脓毒性休克中肾素-血管紧张素-醛固酮系统(RAAS)的改变。实验模型和人类研究证据提示,脓毒性休克时RAAS改变可发生在三个层面:血管紧张素II生成受损(可能归因于血管紧张素转换酶活性缺陷)、肽酶使血管紧张素II降解增强、以及血管紧张素II 1型(AT1)受体因内化或合成减少而不可用。这些改变可单独或联合出现,最终导致RAAS输入与下游AT1受体信号脱耦联。外源性血管紧张素II输注能否充分解决所有这些机制尚不清楚,可能需要额外干预;更深入理解RAAS改变有助于区分患者表型并实施靶向干预。
要点
- 脓毒性休克时RAAS改变可发生在三个层面:血管紧张素II生成受损、肽酶降解增强、AT1受体不可用。
- 上述改变可单独或联合出现,最终导致RAAS输入与下游AT1受体信号脱耦联。
- 血管紧张素II生成受损可能归因于血管紧张素转换酶活性缺陷。
- AT1受体不可用可归因于受体内化或合成减少。
- 外源性血管紧张素II输注能否充分解决所有这些机制尚不清楚,可能需要额外干预。
适用人群与场景
- 脓毒性休克患者(实验模型和人类研究证据)
研究设计与关键结果
- 综述指出,脓毒性休克时RAAS改变可发生在三个层面:1. 血管紧张素II生成受损,可能归因于血管紧张素转换酶活性缺陷;2. 肽酶使血管紧张素II降解增强;3. AT1受体因内化或合成减少而不可用。
- 这些改变可单独或联合出现,最终导致RAAS输入与下游AT1受体信号脱耦联。
- 外源性血管紧张素II输注能否充分解决所有这些机制尚不清楚,可能需要额外干预。
证据类型、等级与局限
- 证据类型:综述(基于实验模型和人类研究证据)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,这些观察开辟了新的研究途径,并提供了改善患者预后的新治疗策略的潜力。
- 作者认为,在不久的将来,更深入理解脓毒性休克中RAAS改变应有助于区分患者表型并实施靶向干预。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Recent years have seen a resurgence of interest for the renin-angiotensin-aldosterone system in critically ill patients. Emerging data suggest that this vital homeostatic system, which plays a crucial role in maintaining systemic and renal hemodynamics during stressful conditions, is altered in septic shock, ultimately leading to impaired angiotensin II-angiotensin II type 1 receptor signaling. Indeed, available evidence from both experimental models and human studies indicates that alterations in the renin-angiotensin-aldosterone system during septic shock can occur at three distinct levels: 1. Impaired generation of angiotensin II, possibly attributable to defects in angiotensin-converting enzyme activity; 2. Enhanced degradation of angiotensin II by peptidases; and/or 3. Unavailability of angiotensin II type 1 receptor due to internalization or reduced synthesis. These alterations can occur either independently or in combination, ultimately leading to an uncoupling between the renin-angiotensin-aldosterone system input and downstream angiotensin II type 1 receptor signaling. It remains unclear whether exogenous angiotensin II infusion can adequately address all these mechanisms, and additional interventions may be required. These observations open a new avenue of research and offer the potential for novel therapeutic strategies to improve patient prognosis. In the near future, a deeper understanding of renin-angiotensin-aldosterone system alterations in septic shock should help to decipher patients' phenotypes and to implement targeted interventions.
参考来源
- Picod A, Garcia B, Van Lier D, et al. Impaired angiotensin II signaling in septic shock. Ann Intensive Care. 2024. PMID: 38877367. doi:10.1186/s13613-024-01325-y
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。